Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU TONKIN : revenue, balance sheet and financial ratios

PHARMACIE DU TONKIN is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BILLERE (64140), this company of category PME shows in 2024 a net income positive of 96 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU TONKIN (SIREN 527612154)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 95 996 € 50 438 € 108 284 € 87 865 € 62 563 € 64 765 € 93 462 € 83 885 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

En 2024, PHARMACIE DU TONKIN genera un resultado neto positivo de 96 k€. Evolución 2016-2024: 84 k€ -> 96 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

95 996 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 19%. Este nivel muy bajo refleja una estructura financiera sólida. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 74%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

18.991%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

74.322%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

50.3%

Solvency indicators evolution
PHARMACIE DU TONKIN

Sector positioning

Ratio de endeudamiento
18.99 2024
2021
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Bueno -7 pts over 3 years

En 2024, el ratio de endeudamiento de PHARMACIE DU TONKIN (18.99) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.

Autonomía financiera
74.32% 2024
2021
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Excelente +14 pts over 3 years

En 2024, el autonomía financiera de PHARMACIE DU TONKIN (74.3%) se sitúa en el top 25% del sector. Este ratio representa la parte del patrimonio en la financiación total. Alta autonomía refleja independencia financiera y capacidad para absorber choques.

Liquidity ratios

El ratio de liquidez se sitúa en 154.91. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

154.905

Liquidity indicators evolution
PHARMACIE DU TONKIN

Sector positioning

Ratio de liquidez
154.91 2024
2021
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average +14 pts over 3 years

En 2024, el ratio de liquidez de PHARMACIE DU TONKIN (154.91) se sitúa por debajo de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Una mejora fortalecería la posición competitiva.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería. Plazo medio de cobro a clientes: 238 días. Plazo proveedores: 791 días. Excelente situación: los proveedores financian 553 días del ciclo operativo.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

238 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

791 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DU TONKIN

Positioning of PHARMACIE DU TONKIN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DU TONKIN is estimated at 1 340 175 € (range 933 276€ - 2 004 978€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
933k€ 1340k€ 2004k€
1 340 175 € Range: 933 276€ - 2 004 978€
NAF 5 année 2024

Valuation method used

Net Income Multiple
95 996 € × 14.0x = 1 340 175 €
Range: 933 277€ - 2 004 979€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU TONKIN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU TONKIN

What is the revenue of PHARMACIE DU TONKIN ?

The revenue of PHARMACIE DU TONKIN is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DU TONKIN profitable?

Yes, PHARMACIE DU TONKIN generated a net profit of 96 k€ in 2024.

Where is the headquarters of PHARMACIE DU TONKIN ?

The headquarters of PHARMACIE DU TONKIN is located in BILLERE (64140), in the department Pyrenees-Atlantiques.

Where to find the tax return of PHARMACIE DU TONKIN ?

The tax return of PHARMACIE DU TONKIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU TONKIN operate?

PHARMACIE DU TONKIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.